Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Beyond The Mask: Innovation & Opportunities For CRNAs

A Groundbreaking Product to Improve Airway Management

28 Mar 2024

Description

Most CRNAs have come up with solutions in the operating room for airway management, but today’s guest took it a step further and developed a product to address issues we face as patient body types change. Roxanne McMurray, DNP, CRNA, APRN, FAANA takes us on her journey from recognizing the urgent need for better tools to inventing a groundbreaking device, the McMurray Enhanced Airway. As patient demographics shift and sedation practices evolve, Roxanne shares the challenges anesthesia providers encounter and the creative, patient-centric solutions that are emerging. Our discussion unveils how these innovations not only enhance safety and comfort but also reflect the ingenuity that CRNAs bring to the operating table.   Here’s some of what we discuss in this episode: How she came up with the idea and what it took to make it a reality. The process for developing and securing a medical patent. How products are tested to see how long they will last. Roxanne shares stories and outcomes they’ve experienced so far with the product being used. How this compares to CPAP devices.   About our guest: https://www.mcmurraymed.com/   Visit us online: https://beyondthemaskpodcast.com/   Get the CE Certificate here: https://beyondthemaskpodcast.com/wp-content/uploads/2020/04/Beyond-the-Mask-CE-Cert-FILLABLE.pdf   Help us grow by leaving a review: https://podcasts.apple.com/us/podcast/beyond-the-mask-innovation-opportunities-for-crnas/id1440309246   Donate to Our Heart Your Hands here: https://www.ourheartsyourhands.org/donate 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.